Immuno-Augmentive Therapy (IAT)
The objective of IAT is to restore the cancer patient’s immune competency to a level by which it can control cancer. The therapy involves injecting patients with blood fractions (deficient in cancer patients) to redress the deficiency. Patients continue to self-administer the injections from serum for whatever length of time is necessary.
Burton’s Immuno-Augmentative Therapy
IAT Treatment Objectives
The objective of IAT is to restore the cancer patient’s immune competency to a level by which it can control cancer. The body’s own complex tumor fighting system may well be the first, the best, and the last line of defense against cancers. Other than surgical intervention for local tumors, there is generally no cure for most cancers. Restoring the immune system to enable it to destroy cancer cells, therefore, becomes the prime objective in IAT…
…Dr. Lawrence Burton uses four blood proteins – substances occurring naturally in the body – to treat cancer. His Immuno-Augmentative Therapy (IAT), developed while he was a senior oncologist at St. Vincent’s Hospital in New York City in the 1960s, does not “attack” the cancer. Instead, it aims to restore normal immune system functioning so the patient’s own immune system will destroy the cancer cells. Ask yourself what happened to the following evidence in the ensuing forty years. Burton discovered that the components of the blood, which he called blood fractions, are deficient in the cancer patient. When they are present in correct balance, they work synergistically to control cancer cell growth and kill tumors.
His therapy involves replenishing the deficient blood fractions by injecting patients with them in amounts based on daily or twice-daily blood analyses. Patients continue to self-administer the injections from serum for whatever length of time is necessary, much like a diabetic takes insulin. IAT is non-toxic and has no side effects.
Dr. Burton does not claim that IAT is a cure. He describes it as a means to control and combat cancer. Yet, according to clinical records, 50 to 60% of patients experience tumor reduction. Many undergo long-term regression. Some, even those with terminal cancer , have achieved complete remission .
Many cases of metastatic cancer of the colon and abdomen, treated with Burton’s IAT, have gone well beyond five years of recovery. This is a remarkable achievement since the National Cancer Institute says these types of cancer have a zero five-year survival rate. There is a clinic in the Bahamas treating patients today based on Burton’s theory.
Patient Finds Successful Alternative Treatment In The Bahamas
Ruth Phillips took her eight-months-to-live, mesothelioma diagnosis from one highly regarded cancer center to another — from Atlanta to New York to Washington, D.C. — and it hardly changed. Doctors painted a picture she refused to accept.
So she gambled. And won.
Phillips flew to Freeport, Bahamas, not for the sun and the fun and not to spend her final days at some glitzy casino resort. She rolled the dice in a different game, stepping into a controversial, outside-the-box, alternative treatment clinic that looked nothing like the fancy cancer centers she had been visiting.
That was 12 years ago. Today Phillips is thriving, returning home from another workout at a local gymnasium, preparing to make dinner for her husband, not worried about the mesothelioma that should have killed her long ago.
“If I wouldn’t have found that little clinic, I would have been dead the last 11 years,” Phillips said last week by phone from her home in Rome, Georgia. “It worked for me. All the doctors at the big centers back then just sort of apologized to me for getting mesothelioma. They didn’t give me any hope of living another year. I found it somewhere else.” …continue reading full article at Asbestos.com
Based on the anecdotal reports of patients, in most cases the short-term side-effects of IAT appear minor (426). John Clement, an IRC physician, states that IAT is generally non-toxic, and the few side-effects reported have been minor (e.g., fatigue, malaise, pain at the site of injection or at bony metastasis, flu-like symptoms, somnolence). Study
Where can I get this treatment and more information?